Bank of New York Mellon’s Alamar Biosciences ALMR Stock Holding History

Bank of New York Mellon’s Portfolio ALMR Stock Details ALMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$881K	Buy	+32,514	New	+$736K	﹤0.01%	3443

Other funds holding ALMR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

DACS

Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of New York Mellon's ALMR Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Alamar Biosciences (ALMR) in Q2 2026: 32,514 shares worth $881K. The stake represents ﹤0.01% of the portfolio and ranks #3443 among its holdings.

17 funds tracked by Wall St. Rank hold ALMR as of Q2 2026.

Bank of New York Mellon held 32,514 shares of Alamar Biosciences worth $881K as of Q2 2026.
Alamar Biosciences was a new Bank of New York Mellon position in Q2 2026.
Alamar Biosciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3443 holding.
17 funds tracked by Wall St. Rank held Alamar Biosciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.